Latest news
Boryung Posts Record First-Half Revenue and Operating Profit as Taxotere and CDMO Global Performance Materializes - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 09:06:00 GMTBoryung grows sales but sees Q2 profit dip after Kanarb price cut in Korea - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 06 Aug 2026 08:24:00 GMTBoryung Posts Record First-Half Results on Taxotere, CDMO Global Sales - Seoul Economic DailySeoul Economic Daily · Thu, 06 Aug 2026 07:59:37 GMTBoryung Corporation Revenue Breakdown – KRX:003850 - TradingViewTradingView · Wed, 29 Jul 2026 05:57:07 GMTBoryung buys Taxotere rights, builds global anticancer supply chain - CHOSUNBIZ - ChosunbizChosunbiz · Tue, 28 Jul 2026 07:00:00 GMT